CHU Dijon Bourgogne
Dijon, 21000, France
Location status: Recruiting
NCT Number: NCT06692751
Microvascular angina is thought to affect around 112 million patients worldwide. However, this figure is underestimated due to the difficulty of making the diagnosis. It is a pathology caused by an alteration in the microcirculation of the heart muscle, which is not detectable on a standard coronary angiogram.
In view of its prognostic, therapeutic and medico-economic value, scientific societies currently recommend invasive measurement of the microcirculatory resistance index (MRI) to diagnose microvascular angina, in the absence of significant lesions on coronary angiography.
Several research teams, including our own, have shown that cardiovascular risk is associated with alterations in the vascularization of the small vessels (microcirculation) of the retina. Unlike the study of cardiac vessels, the study of retinal microcirculation using fundus photography (OCT-A) is simple, rapid, non-invasive and inexpensive. It appears to be an interesting alternative to the measurement of IMR for the diagnosis of microvascular angina.
This hypothesis has never yet been tested. The demonstration of an association between a decrease in retinal vascular density measured by OCT-A and an alteration in coronary microvascular function measured by IMR would pave the way for a completely non-invasive diagnosis of patients.
This is an observational, cohort, prospective, single-center pilot study comparing people who have received an IMR measurement as part of INOCA.
It is planned to include 158 participants. The overall follow-up period for each patient in the research is 12 months.
In routine care, IMR is measured during coronary angiography in patients presenting with ischemia on a non-invasive test and/or stress symptoms such as angina or dyspnea, for whom coronary angiography does not reveal any significant epicardial lesion.
Following this examination, two groups will be formed: a group with an IMR<25 and a group with an IMR≥25. Clinically, the study aims to determine the potential role of retinal OCT-A as a non-invasive examination for the diagnosis and/or follow-up of INOCA.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Dijon, 21000, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2 tubes of 5 mL
angiographic optical coherence tomography (OCT-A) on both eyes after pupil dilation.
An optional 20-30 minute WLR may be offered following OCT-A.
at inclusion, 3 months and 1 year Estimated filling time: 2 minutes
Time frame: At baseline
Contact information is provided by the study sponsor or research team.
Centre Hospitalier Universitaire Dijon
Other
Acronym: EYE-NOCA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07449325
Angina Pectoris, Cardiovascular Diseases
New Haven, Connecticut, United States
View Trial DetailsNCT06070662
Angina Pectoris, Cardiovascular Diseases
Leicester, Leicestershire, United Kingdom
View Trial DetailsNCT04674449
Angina Attacks, Angina Pectoris
Cork, Ireland
View Trial DetailsNCT07196397
Angina Pectoris, Angina Pectoris, Variant
Rzeszów, Poland
View Trial Details